Puma Biotechnology (NASDAQ:PBYI) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Puma Biotechnology (PBYI) operate in?

Puma Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Puma Biotechnology Stock (NASDAQ: PBYI) stock price, news, charts, stock research, profile.

Open	$2.53
Close	$2.60
Volume / Avg.	596.32K / 472.46K
Day Range	$2.50 - $2.67
52 Wk Range	2.13 - 7.73
Market Cap	$125.42M
P/E Ratio	13.47
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	8.52%
Days to Cover	9.14

Recent News

Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute

A Delaware jury ordered AstraZeneca to pay Pfizer $107.5 million, ruling that AstraZeneca's lung cancer drug Tagrisso infringed on Pfizer's patents related to cancer treatment.

Vandana Singh

Puma Biotechnology's Q1 Earnings and Revenues Beat

Puma Biotechnology, Inc. (NASDAQ: PBYI) reported first-quarter 2024 adjusted loss of 5 cents per share, which was narrower than the Zacks Consensus Estimate of a loss of 16 cents. In the year-ago quarter, the company had reported adjusted earnings of 9 cents.

Zacks

Why Nanobiotix Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket

Gainers Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT) shares surged 39.3% to $0.6621 in pre-market trading after gaining around 14% on Wednesday.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

About Puma Biotechnology Inc

Sector

Health Care

Industry

Biotechnology

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative pr...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Puma Biotechnology (PBYI) stock?

You can purchase shares of Puma Biotechnology (NASDAQ:PBYI) through any online brokerage.

View our list of the best stock brokerages

Who are Puma Biotechnology (PBYI) competitors?

Other companies in Puma Biotechnology’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Anixa Biosciences (NASDAQ:ANIX), Citius Oncology (NASDAQ:CTOR), Adicet Bio (NASDAQ:ACET) and Agenus (NASDAQ:AGEN).

What is the forecast, or price target, for Puma Biotechnology (PBYI) stock?

There is no analysis for Puma Biotechnology to provide a consensus price target.

What is the current price for Puma Biotechnology (PBYI)?

The stock price for Puma Biotechnology (NASDAQ: PBYI) is $2.6 last updated September 20, 2024 at 4:00 PM EDT.

Does Puma Biotechnology (PBYI) pay a dividend?

There are no upcoming dividends for Puma Biotechnology.

When is Puma Biotechnology (NASDAQ:PBYI) reporting earnings?

Puma Biotechnology does not have any upcoming earnings scheduled.

Is Puma Biotechnology (PBYI) going to split?

There is no upcoming split for Puma Biotechnology.

What sector and industry does Puma Biotechnology (PBYI) operate in?

Puma Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Get Our Top Trade Ideas Delivered Daily - 65% Off Now